Legend Biotech CorpNASDAQ:LEGN
- LAST PRICE49.9100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots50.0000/ 1
- Ask / Lots51.3000/ 1
- Open / Previous Close--- / 49.9100
- Day Range---
- 52 Week Range
- Volume6
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LEGN |
|---|---|---|
| 09:32 ET | 1084 | 51.18 |
| 09:38 ET | 300 | 51.36 |
| 09:39 ET | 100 | 50.81 |
| 09:45 ET | 200 | 51.135 |
| 09:50 ET | 523 | 51.52 |
| 09:52 ET | 405 | 51.29 |
| 09:56 ET | 520 | 51.425 |
| 09:57 ET | 1011 | 51.02 |
| 09:59 ET | 300 | 51.03 |
| 10:03 ET | 300 | 51.33 |
| 10:06 ET | 820 | 50.9 |
| 10:08 ET | 200 | 50.93 |
| 10:10 ET | 426 | 50.88 |
| 10:12 ET | 1100 | 50.76 |
| 10:14 ET | 401 | 50.625 |
| 10:15 ET | 2530 | 50.5 |
| 10:17 ET | 1282 | 50.57 |
| 10:19 ET | 3594 | 50.31 |
| 10:21 ET | 570 | 50.38 |
| 10:24 ET | 2473 | 50.39 |
| 10:26 ET | 1096 | 50.525 |
| 10:28 ET | 300 | 50.55 |
| 10:30 ET | 2288 | 50.63 |
| 10:32 ET | 499 | 50.83 |
| 10:35 ET | 600 | 50.79 |
| 10:37 ET | 400 | 50.79 |
| 10:39 ET | 100 | 50.77 |
| 10:42 ET | 900 | 50.695 |
| 10:44 ET | 654 | 50.79 |
| 10:46 ET | 400 | 50.91 |
| 10:48 ET | 700 | 50.91 |
| 10:50 ET | 1407 | 50.78 |
| 10:51 ET | 604 | 50.84 |
| 10:53 ET | 300 | 50.91 |
| 10:55 ET | 100 | 50.835 |
| 10:57 ET | 300 | 50.91 |
| 11:00 ET | 300 | 50.94 |
| 11:02 ET | 300 | 50.94 |
| 11:04 ET | 300 | 50.95 |
| 11:06 ET | 400 | 50.875 |
| 11:08 ET | 900 | 50.89 |
| 11:09 ET | 500 | 50.69 |
| 11:11 ET | 100 | 50.85 |
| 11:13 ET | 1723 | 50.69 |
| 11:15 ET | 800 | 50.78 |
| 11:18 ET | 300 | 50.65 |
| 11:20 ET | 300 | 50.76 |
| 11:22 ET | 400 | 50.69 |
| 11:24 ET | 857 | 50.73 |
| 11:26 ET | 100 | 50.55 |
| 11:29 ET | 608 | 50.57 |
| 11:31 ET | 200 | 50.53 |
| 11:33 ET | 1100 | 50.44 |
| 11:36 ET | 400 | 50.44 |
| 11:38 ET | 100 | 50.37 |
| 11:40 ET | 200 | 50.425 |
| 11:42 ET | 700 | 50.34 |
| 11:44 ET | 200 | 50.29 |
| 11:47 ET | 4398 | 50.135 |
| 11:49 ET | 460 | 50.11 |
| 11:51 ET | 100 | 50.22 |
| 11:54 ET | 660 | 50.225 |
| 11:56 ET | 2363 | 50.295 |
| 11:58 ET | 100 | 50.33 |
| 12:00 ET | 366 | 50.29 |
| 12:03 ET | 600 | 50.21 |
| 12:05 ET | 820 | 50.235 |
| 12:09 ET | 200 | 50.31 |
| 12:12 ET | 200 | 50.325 |
| 12:16 ET | 300 | 50.38 |
| 12:21 ET | 200 | 50.335 |
| 12:23 ET | 200 | 50.335 |
| 12:25 ET | 100 | 50.34 |
| 12:27 ET | 1084 | 50.29 |
| 12:32 ET | 200 | 50.36 |
| 12:34 ET | 200 | 50.32 |
| 12:39 ET | 400 | 50.42 |
| 12:41 ET | 200 | 50.54 |
| 12:43 ET | 200 | 50.4 |
| 12:50 ET | 152 | 50.51 |
| 12:54 ET | 200 | 50.45 |
| 12:56 ET | 110 | 50.39 |
| 12:57 ET | 738 | 50.55 |
| 01:01 ET | 213 | 50.565 |
| 01:08 ET | 700 | 50.47 |
| 01:10 ET | 400 | 50.46 |
| 01:12 ET | 390 | 50.46 |
| 01:17 ET | 200 | 50.54 |
| 01:19 ET | 400 | 50.545 |
| 01:21 ET | 300 | 50.585 |
| 01:24 ET | 200 | 50.61 |
| 01:26 ET | 1100 | 50.75 |
| 01:28 ET | 269 | 50.765 |
| 01:30 ET | 312 | 50.82 |
| 01:32 ET | 100 | 50.755 |
| 01:33 ET | 500 | 50.755 |
| 01:35 ET | 100 | 50.85 |
| 01:37 ET | 400 | 50.85 |
| 01:39 ET | 1617 | 50.895 |
| 01:42 ET | 300 | 50.895 |
| 01:44 ET | 800 | 50.945 |
| 01:48 ET | 5360 | 50.86 |
| 01:50 ET | 600 | 50.73 |
| 01:51 ET | 660 | 50.86 |
| 01:53 ET | 460 | 50.85 |
| 01:55 ET | 3050 | 50.78 |
| 01:57 ET | 941 | 50.78 |
| 02:00 ET | 2326 | 50.745 |
| 02:02 ET | 4331 | 51.32 |
| 02:04 ET | 460 | 51.33 |
| 02:06 ET | 2085 | 51.51 |
| 02:08 ET | 2248 | 51.265 |
| 02:09 ET | 1100 | 51.31 |
| 02:11 ET | 2905 | 51.135 |
| 02:13 ET | 1579 | 50.855 |
| 02:15 ET | 2981 | 51.12 |
| 02:18 ET | 1992 | 51.13 |
| 02:20 ET | 300 | 51.185 |
| 02:22 ET | 2815 | 51.03 |
| 02:24 ET | 6176 | 51.075 |
| 02:26 ET | 1200 | 51.075 |
| 02:27 ET | 1140 | 51.095 |
| 02:29 ET | 2101 | 51.01 |
| 02:31 ET | 1761 | 51.105 |
| 02:33 ET | 10688 | 51.13 |
| 02:36 ET | 840 | 51.215 |
| 02:38 ET | 12448 | 51.06 |
| 02:40 ET | 21434 | 51.32 |
| 02:42 ET | 700 | 51.25 |
| 02:44 ET | 4677 | 51.105 |
| 02:45 ET | 4359 | 51 |
| 02:47 ET | 3140 | 50.99 |
| 02:49 ET | 1405 | 50.91 |
| 02:51 ET | 600 | 50.99 |
| 02:54 ET | 14519 | 51.08 |
| 02:56 ET | 400 | 51.08 |
| 02:58 ET | 2151 | 51.155 |
| 03:00 ET | 1001 | 50.98 |
| 03:02 ET | 400 | 50.885 |
| 03:03 ET | 614 | 50.765 |
| 03:07 ET | 900 | 50.625 |
| 03:09 ET | 400 | 50.74 |
| 03:12 ET | 700 | 50.635 |
| 03:14 ET | 1361 | 50.84 |
| 03:16 ET | 300 | 50.77 |
| 03:18 ET | 400 | 50.76 |
| 03:20 ET | 500 | 50.74 |
| 03:21 ET | 1529 | 50.45 |
| 03:23 ET | 2100 | 50.415 |
| 03:25 ET | 900 | 50.56 |
| 03:27 ET | 600 | 50.64 |
| 03:30 ET | 1860 | 50.65 |
| 03:32 ET | 5500 | 50.49 |
| 03:34 ET | 5339 | 50.44 |
| 03:36 ET | 5541 | 50.28 |
| 03:38 ET | 4500 | 50.235 |
| 03:39 ET | 3404 | 50.29 |
| 03:41 ET | 4378 | 50.27 |
| 03:43 ET | 4284 | 50.2 |
| 03:45 ET | 4238 | 50.11 |
| 03:48 ET | 3500 | 49.96 |
| 03:50 ET | 6485 | 49.84 |
| 03:52 ET | 5091 | 49.935 |
| 03:54 ET | 6968 | 49.975 |
| 03:56 ET | 17749 | 49.935 |
| 03:57 ET | 6108 | 50.08 |
| 03:59 ET | 99116 | 49.91 |
Sep 6, 2024
DJ Legend Biotech Down Over 10%, on Pace for Largest Percent Decrease Since July 2022 -- Data Talk, from 12:55PM ET on Friday Sep 06, 2024 by Dow Jones
12:55PM ET on Friday Sep 06, 2024 by Dow Jones
Aug 28, 2024
DJ Legend Biotech Price Target Maintained With a $73.00/Share by HC Wainwright & Co., from 6:59AM ET on Wednesday Aug 28, 2024 by Dow Jones
6:59AM ET on Wednesday Aug 28, 2024 by Dow Jones
Aug 20, 2024
Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference, from 8:00AM ET on Tuesday Aug 20, 2024 by Dow Jones
8:00AM ET on Tuesday Aug 20, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Legend Biotech Corp | 9.1B | -31.9x | --- |
Ascendis Pharma A/S | 8.7B | -15.5x | --- |
Intra-Cellular Therapies Inc | 7.9B | -86.6x | --- |
Tempus AI Inc | 7.9B | -6.2x | --- |
Insmed Inc | 12.5B | -13.5x | --- |
Revolution Medicines Inc | 7.4B | -12.1x | --- |
Company Information
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Contact Information
- Headquarters
- 2101 Cottontail LaneSOMERSET, NJ, United States 08873
- Phone
- 732-317-5050
- Fax
- ---
Executives
- Chairman of the Board
- Fangliang Zhang
- Chief Executive Officer, Director
- Ying Huang
- Chief Financial Officer
- Lori Macomber
- Director
- Ye Wang
- Director
- Li Zhu
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.1B |
|---|---|
Revenue (TTM) | $456.0M |
Shares Outstanding | 183.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.13 |
EPS | $-1.57 |
Book Value | $6.88 |
P/E Ratio | -31.9x |
Price/Sales (TTM) | 20.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -81.89% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
